Ignite Creation Date:
2024-05-06 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03556020
Status:
TERMINATED
Last Update Posted:
2022-08-23
First Post:
2018-06-01
Brief Title:
Phase 2 Study to Assess Safety Tolerability and Efficacy of Once Weekly SC Pemziviptadil PB1046 in Subjects With Symptomatic PAH
Sponsor:
PhaseBio Pharmaceuticals Inc
Organization:
PhaseBio Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-01
First Submit QC Date:
June 1 2018
Study First Post Date:
2018-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2022-08-18
Disp First Submit QC Date:
August 18 2022
Disp First Post Date:
2022-08-23
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-08-18
Last Update Post Date:
2022-08-23
Last Update Post Date Type:
ACTUAL